The effects of paroxetine given repeatedly on the 5-HT receptor subpopulations in the rat brain

Psychopharmacology

Volumn 127, Issue 1, 1996, Pages 73-82

  Maj, J ^a   Bijak, M ^a   Dziedzicka Wasylewska, M ^a   Rogoz, R ^a   Rogoz Z ^a   Skuza, G ^a   Tokarski, T ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Brain 5 HT receptor subpopulations; Paroxetine; Pharmacological electrophysiological and binding effects; Repeated treatment

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; IMIPRAMINE; KETANSERIN; PAROXETINE; RADIOLIGAND; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN; BRAIN CORTEX; BRAIN SLICE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; ELECTROPHYSIOLOGY; EXPLORATORY BEHAVIOR; HEAD TWITCH; HIPPOCAMPUS; HYPERTHERMIA; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; SPIKE;

EID: 0029815456     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02805977     Document Type: Article

References (57)

1. Arnt J, Hyttel J, Fredricson Overø K (1984) Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions. Pol J Pharmacol Pharm 36:221-230
2. Bijak M, Tokarski K (1994) Prolonged administration of imipramine and (+)-oxaprotyline, but not citalopram, results in sensitization of the hippocampal CA1 neurons to serotonin ex vivo. Pol J Pharmacol 46: 163-167
3. Blier P, De Montigny C, Chaput Y (1987) Modification of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol 7:24S-35S
4. 2 receptors and the abundancies of 5-HT receptor and the transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat. Brain Res 638: 311-324
5. Chaput Y, De Montigny C, Blier P (1991) Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments an in vivo electrophysiologic study in the rat. Neuropsychopharmacology 5:219-229
6. Corne SJ, Pickering RW, Warner BT (1963) A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol 20:106-120
7. 3H] imipramine binding sites. Mol Pharmacol 23:607-613
8. 2-mediated behavior in the rat following noradrenergic or serotonergic denervation. J Neural Transm [Gen Sect] 84: 19-32
9. Friedman E, Dallob A (1979) Enhanced serotonin receptor activity after chronic treatment with imipramine or amitriptyline. Commun Pychopharmacol 3:89-92
10. Fuxe K, Ögren SO, Agnati LF, Andersson K, Eneroth P (1982) Effects of subchronic antidepressant drug treatment on central serotonergic mechanisms in the male rat. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: molecular mechanisms. Raven Press, New York, pp 91-107
11. Fuxe AS, Ögren SO, Agnati LF, Benfenati F, Fredholm B, Zini J, Eneroth P (1983) Chronic antidepressants treatment and central 5-HT synapses. Neuropharmacology 22:389-400
12. 2 receptors. Br J Pharmacol 84:743-753
13. 2 receptor-mediated head-twitch behaviour following antidepressant treatment to mice. Br J Pharmacol 83:235-242
14. 2, receptor number in frontal cortex. Br J Pharmacol 80:377-385
15. 2 antagonist pirenperone. Neuropharmacology 22:573-578
16. Hensler JG, Kovachich GB, Frazer A (1991) A quantitative autoradiographic study of serotonin 1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131-144
17. Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikström H, Arvidsson L-E, Hacksell U, Nilsson JLG (1982) 8-Hydroxy-2-(di-n-propyloamino)-tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT-receptor stimulating activity. J Neural Transm 55: 169-188
18. Hwang E, Magnussen J, Woert MH (1980) Effects of chronic fluoxetine administration on serotonin metabolism. Res Commun Clin Pathol Pharmacol 29: 79-98
19. Hyttel J (1982) Citalopram pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry 6:277-295
20. Janssen PAJ, Jageneau AHM, Schellekens KHL (1960) Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone. Part IV. Influence of haloperidol (R-1625) and chloropromazine on the behavior of rats in an unfamiliar "open field" situation. Psychopharmacologia 1: 389-392
21. Kellar KJ, Cascio CS, Butler JA, Kurtzke RN (1981) Differential effects of electroconvulsive shock and antidepressant drugs on serotonin-2 receptors in rat brain. Eur J Pharmacol 69: 515-518
22. Kendall DA, Stancel GM, Enna SJ (1981) Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science 211: 1183-1185
23. 1C receptors. Br J Pharmacol 94: 137-147
24. 2C/2B receptor function. Neuropharmacology 33: 1581-1588
25. Klančnik JM, Obenaus A, Philips AG, Baimbridge KG (1991) The effects of serotonergic compounds on evoked responses in the dentate gyrus and CA1 region of the hippocampal formation of the rat. Neuropharmacology 30: 1201-1209
26. 2 receptors after chronic administration of levoprotiline, (+)-oxaprotiline and other antidepressant drugs. Pol J Pharmacol Pharm 44: 549-560
27. 2 receptors in the rat brain. J Psychiatr Neurosci 19:63-67
28. Kłodzińska A, Chojnacka-Wójcik E (1992) Hyperthermia induced by m-trifluoromethyl-phenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adapted rats. Psychopharmacology 109:466-472
29. Kłodzińska A, Jaros T, Chojnacka-Wójcik E, Maj J (1989) Exploratory hypoactivity induced by m-trifluoromethyl-phenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP). J Neural Trans [PD] 1:207-218
30. Koe BK, Wiessman A, Welch WM, Browne RG (1983) Sertraline, IS, 4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthyl amine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 245:969-974
31. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol 352: 141-148
32. 2 receptor binding sites. Mol Pharmacol 21: 301-314
33. Lucki J, Frazer A (1982) Behavioural effects of indole and piperazine type serotonin receptor agonist. Soc Neurosci 8: 101
34. Lund A, Mjellem-Jolly N, Hole K (1992) Desipramine, administered chronically influences 5-hydroxytryptamine 1A-receptors, as measured by behavioural tests and receptor binding in rats. Neuropharmacology 32: 25-32
35. Magnussen J, Tønder K, Engbaek F (1982) Paroxetine, a potent selective long-acting inhibitor of synaptosomal 5-HT uptake in mice. J Neural Trans 55: 217-226
36. 1) and dopamine receptors. In: Proceedings of 9th IUPHAR International Congress of Pharmacology, vol. 3. Plenum Press, London, pp 137-143
37. Maj J (1986) Repeated treatment with antidepressant drugs: responses mediated by brain dopamine receptors. In: Hippius H, Klerman GL, Matussek N (eds) New results in depression research. Springer, Berlin, pp 90-98
38. Maj J, Moryl E (1992) Effect of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J Neural Transm [Gen Sect] 88: 143-156
39. Maj J, Moryl E (1993) Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists. Eur Neuropsychopharmacol 3:85-94
40. 1 recognition site. Eur J Pharmacol 90: 151-153
41. Mogilnicka E, Klimek V (1979) Mianserin, danitracen and amitriptyline withdrawal increase the behavioural responses of rats of L-5-HTP. J Pharm Pharmacol 31: 704-705
42. Ögren SO, Fuxe K, Archer T, Johansson G, Holm AC (1982) Behavioural and biochemical studies on the effects of acute and chronic administration of antidepressant drugs on central serotonergic receptor mechanism. In: Langer SZ, Takahashi R, Segawa T, Briley M (eds) Advances in the biosciences. New vistas in depression, vol. 40. Pergamon Press, Oxford, pp 11-19
43. Ortmann R, Bischoff S, Radeke H, Buech O, Delini-Stula A (1982) Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers. Naunyn-Schmiedeberg's Arch Pharmacol 321: 265-270
44. Peroutka SJ, Snyder HS (1980) Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 210:88-90
45. IC cortical receptors. Naunyn-Schmiedeberg's Arch Pharmacol 346:4-11
46. Ropert N (1988) Inhibitory action of serotonin in CA1 hippocampal neurons in vitro. Neuroscience 26:69-88
47. 3H]-8-OH-DPAT). Biochem Pharmacol 35: 1943-1949
48. 1A agonist. J Pharmacol Exp Ther 273: 101-112
49. Stolz JF, Marsden CA (1982) Withdrawal from chronic treatment with metergoline dl-propranolol and amitriptyline enhances serotonin receptor mediated behavior in the rat. Eur J Pharmacol 79: 17-22
50. 3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behavior. Psychopharmacology 80: 150-155
51. Sulpizio A, Fowler PJ, Macko E (1978) Antagonism of fenfluramine-induced hypothermia: a measure of central serotonin inhibition. Life Sci 22: 1439-1446
52. Thomas DR, Nelson DR, Johnson AM (1987) Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 93: 193-200
53. 1 receptor and catecholaminergic systems in the behavioural response to 8-hydroxy-2(di-n-propyloamino)- tetralin in the rat. Eur J Pharmacol 106: 271-282
54. 2 receptors and transport sites for serotonin. Brain Res 615:87-94
55. 1A receptors in rat brain following antidepressant drug treatment. Synapse 4: 347-352
56. Wong DT, Horng JS, Bymaster FP, Hauser KL (1974) A selective inhibitor of serotonin uptake: Lilly 110140 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci 15: 471-479
57. Wong DT, Threlkeld PG, Robertson DW (1991) Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors. Neuropsychopharmacology 5:43-47